Belgian scientists in Nature with cancer breakthrough

April 16, 2015 News BioVox

Scientists Peter Carmeliet and Sarah-Maria Fendt (KU Leuven/VIB) published in the prestigious Nature journal on their fundamental breakthrough in cancer research. They found a new way to prevent blood vessel formation by blocking the enzyme CPT1a. Tumors obtain nutrients for growth from blood vessels. CPT1a is necessary in endothelial cells to break down fatty acids. This appeared to inhibit the proper formation of DNA and subsequently cell division. In this way blood vessels, necessary for the growth of tumors, can no longer be formed.

Read more about this breakthrough in our Insights Article. Subscribe to our newsletter to stay up to date.

Avatar photo

With a local focus and global reach, BioVox shares insights into the Belgian life sciences ecosystem with an ever-growing global community. BioVox is a non-profit project: we are able to provide our community with free, quality content because of the generous support of Turnstone Communications and its clients. Our articles bring you hidden opportunities and exclusive insights into the latest research and industry trends!

All posts